HB 1536 (2020): relative to pharmacists-in-charge, the inspection and regulation of prescription drugs by the pharmacy board, and disciplinary actions by the pharmacy board.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “HB 1536 (2020): relative to pharmacists-in-charge, the inspection and regulation of prescription drugs by the pharmacy board, and disciplinary actions by the pharmacy board.” Granite Record, https://graniterecord.org/bill/2020/hb1536. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). HB 1536 (2020): relative to pharmacists-in-charge, the inspection and regulation of prescription drugs by the pharmacy board, and disciplinary actions by the pharmacy board. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2020/hb1536
- Chicago
- Granite Record. “HB 1536 (2020): relative to pharmacists-in-charge, the inspection and regulation of prescription drugs by the pharmacy board, and disciplinary actions by the pharmacy board.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2020/hb1536.
- BibTeX
@misc{bill-2020-hb1536, title = {HB 1536 (2020): relative to pharmacists-in-charge, the inspection and regulation of prescription drugs by the pharmacy board, and disciplinary actions by the pharmacy board.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2020/hb1536}, note = {Accessed 24 Oct. 2026} }
HB 1536 (2020)
relative to pharmacists-in-charge, the inspection and regulation of prescription drugs by the pharmacy board, and disciplinary actions by the pharmacy board.
- Status: Referred for interim study
- Term: 2019-2020
- House committee: Executive Departments and Administration
- Subject: Occupational Regulation
The Story
It was introduced on January 8, 2020 and referred to the House Executive Departments and Administration committee. The committee held a public hearing on February 4, 2020. The committee held a work session on March 3, 2020. The committee met in executive session on March 3, 2020 to vote on its recommendation. The committee voted unanimously, 19–0, to recommend that the House study it after the session ends, and the report was placed on the consent calendar. On March 11, 2020 the House voted to study it after the session ends on a voice vote. The committee held a work session on September 15, 2020. The committee reported back on its interim study of the bill: “Recommended for Future Legislation”, by a vote of 16 to 0.
Sponsors
- Rep. Gary Merchant (D - Sull 4) (prime sponsor)
Hearings and Sessions
- February 4, 2020, 11:00 AM: public hearing, House Executive Departments and Administration, LOB 306
- March 3, 2020, 10:00 AM: subcommittee work session, House Executive Departments and Administration, LOB 306
- March 3, 2020, 1:00 PM: executive session, House Executive Departments and Administration, LOB 306
- September 15, 2020, 2:00 PM: full committee work session, House Executive Departments and Administration
Votes
- March 11, 2020, House: Refer for Interim Study — voice vote, passed
The Docket
- January 8, 2020: Introduced 01/08/2020 and referred to Executive Departments and Administration
- February 4, 2020: Public Hearing: 02/04/2020 11:00 am LOB 306
- March 3, 2020: Subcommittee Work Session: 03/03/2020 10:00 am LOB 306
- March 3, 2020: Executive Session: 03/03/2020 01:00 pm LOB 306
- March 11, 2020: Committee Report: Refer for Interim Study for 03/11/2020 (Vote 19-0; CC)
- March 11, 2020: Refer for Interim Study: MA VV 03/11/2020
- September 15, 2020: Full Committee Work Session: 09/15/2020 02:00 pm Members of the public may attend using this link: : https://www.zoom.us/j/95529579162 - Executive Session to Follow
- October 2, 2020: Interim Study Report: Recommended for Future Legislation (Vote 16-0)